DC Chemicals Limited
China
Product Name: Clodronate disodium tetrahydrate
Price: $300.0/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

88416-50-6

88416-50-6 structure

Name: Clodronate disodium tetrahydrate
Chemical Name: Disodium Clodronate Tetrahydrate
CAS Number: 88416-50-6
Molecular Formula: CH₁₂Cl₂Na₂O₁₀P₂
Molecular Weight: 360.917
Catalog: analytical chemistry Standard Pharmacopoeia Standards and Magazine Standards
Create Date: 2018-07-20 19:08:56
Modify Date: 2024-01-03 09:43:43
Clodronate disodium tetrahydrate (Disodium clodronate tetrahydrate) is first-generation bisphosphonate, with anti-osteoporotic, anti-inflammatory and analgesic effects. Clodronate disodium tetrahydrate is a selective, potent, reversible and Cl- competitive vesicular nucleotide transporter (VNUT) inhibitor, with an IC50 of 15.6 nM. Clodronate disodium tetrahydrate inhibits vesicular ATP release from neurons and reduces chronic neuropathic and inflammatory pain[1][2].

Name	Disodium Clodronate Tetrahydrate
Synonyms	Sodium (dichloromethylene)bis[hydrogen (phosphonate)] hydrate (2:1:4) Phosphonic acid, (dichloromethylene)bis-, sodium salt, hydrate (1:2:4) Disodium clodronate tetrahydrate clodronate disodium tetrahydrate Clodronate Disodium

Description	Clodronate disodium tetrahydrate (Disodium clodronate tetrahydrate) is first-generation bisphosphonate, with anti-osteoporotic, anti-inflammatory and analgesic effects. Clodronate disodium tetrahydrate is a selective, potent, reversible and Cl- competitive vesicular nucleotide transporter (VNUT) inhibitor, with an IC50 of 15.6 nM. Clodronate disodium tetrahydrate inhibits vesicular ATP release from neurons and reduces chronic neuropathic and inflammatory pain[1][2].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology Research Areas >> Neurological Disease
Target	vesicular ATP release[1]
In Vitro	Clodronate disodium tetrahydrate, a first-generation bisphosphonate, significantly attenuates neuropathic and inflammatory pain unrelated to bone abnormalities via inhibition of VNUT, a key molecule for the initiation of purinergic chemical transmission [1]. Clodronate disodium tetrahydrate is an allosteric modulator of VNUT Cl- dependence [1]. Clodronate disodium tetrahydrate acts as antiresorptive in osteoporosis[2].
In Vivo	Clodronate disodium tetrahydrate (10 mg/kg; i.v.) attenuates inflammatory pain via VNUT inhibition[1]. Clodronate disodium tetrahydrate attenuates inflammation via VNUT inhibition [1]. Animal Model: C57BL/6 mice (22-30 g)[1] Dosage: 10 mg/kg Administration: Intravenous injection Result: Attenuated carrageenan- or complete Freund’s adjuvant (CFA)-evoked inflammatory pain.
References	[1]. Kato Y, et al. Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6297-E6305. [2]. Moriyama Y, et al. Clodronate: A Vesicular ATP Release Blocker. Trends Pharmacol Sci. 2018 Jan;39(1):13-23.

Molecular Formula	CH₁₂Cl₂Na₂O₁₀P₂
Molecular Weight	360.917
Exact Mass	359.892151
PSA	177.26000
LogP	1.04990

88416-50-6	22560-50-5
1315337-40-6	10596-23-3
14025-21-9	12008-41-2
165800-07-7	12045-87-3
71519-72-7	6190-45-0